 |
Corporate News
04-May-22
|
|
|
|
|
|
|
|
|
|
|
|
Gland Pharma announces launch of Bortezomib for Injection in US market
|
|
USed in treatment of certain types of cancer
|
|
|
|
|
|
Gland Pharma through its partner has launched Bortezomib for Injection, 3.5 mg/vial, Single-Dose Vial in the US Market. It is the bioequivalent and therapeutically equivalent to thereference listed drug (RLD), Velcade® for Injection, 3.5 mg/vial of Takeda Pharmaceuticals U.S.A., Inc.
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma.
Velcade has a market size of USD 1,172 million for the twelve months ending March 2022, according to IQVIA.
Gland Pharma's partner has received the ANDA approval for the product from U.S. Food & Drug Administration (US FDA). Gland Pharma is manufacturing and supplying this product to its partner for the US
market.
|
|
|
|
Previous News |
Stock alert: Indus Towers, Gland Pharma, Advanced Enzyme, DMart, Sapphire Foods
(
Market Commentary
-
Stock Alert
20-Jun-24
08:50
)
|
|
|
Volumes spurt at Gland Pharma Ltd counter
(
Hot Pursuit
-
07-Nov-23
11:00
)
|
|
|
Gland Pharma rallies on USFDA nod for breast cancer drug
(
Hot Pursuit
-
08-Apr-24
13:18
)
|
|
|
Gland Pharma consolidated net profit rises 144.56% in the March 2024 quarter
(
Results
-
Announcements
23-May-24
07:36
)
|
|
|
Gland Pharma Ltd gains for fifth session
(
Hot Pursuit
-
11-Jun-24
13:00
)
|
|
|
Gland Pharma Q2 PAT declines 19% YoY to Rs 194 cr
(
Hot Pursuit
-
07-Nov-23
10:26
)
|
|
|
Gland Pharma Ltd spurts 2.75%, up for third straight session
(
Hot Pursuit
-
23-Mar-23
13:05
)
|
|
|
Gland Pharma Q3 PAT slides 15% YoY to Rs 232 cr
(
Hot Pursuit
-
24-Jan-23
09:43
)
|
|
|
Gland Pharma drops after Q2 PAT slides 20% to Rs 241 cr
(
Hot Pursuit
-
27-Oct-22
10:28
)
|
|
|
Gland Pharma Ltd leads losers in 'A' group
(
Hot Pursuit
-
22-May-23
15:00
)
|
|
|
Gland Pharma consolidated net profit declines 20.14% in the September 2022 quarter
(
Results
-
Announcements
27-Oct-22
08:12
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|